Institutional members access full text with Ovid®

Share this article on:

L-dopa and the patient with Parkinson's disease

AJN The American Journal of Nursing: July 1969
Natural Childbirth: PDF Only

In a recent editorial, The New England Journal of Medicine called L-dopa “the most important contribution to medical therapy of a neurologic disease in the past 50 years.” For the past two years, clinical investigations have been conducted at several research centers on the use of large doses of this amino acid for the relief of many of the disabling symptoms of Parkinson's diseases. Here is a description of the effects of the drug with some guidelines about the nursing care that the patients who are on it require.

© Lippincott-Raven Publishers.